Renaissance Technologies’s NeuroSense Therapeutics NRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,100	Closed	-$129K	–	3819
2024 Q1	$129K	Buy	+71,100	New	+$129K	﹤0.01%	3322
2023 Q1	–	Sell	-18,433	Closed	-$22K	–	4266
2022 Q4	$22K	Sell	18,433 -35,867	-66%	-$42.8K	﹤0.01%	3946
2022 Q3	$97K	Buy	+54,300	New	+$97K	﹤0.01%	3606